Guangdong Jiaying Pharmaceutical Co., Ltd (SHE:002198)
3.820
-0.060 (-1.55%)
Sep 8, 2026, 3:04 PM CST
SHE:002198 Revenue
Guangdong Jiaying Pharmaceutical had revenue of 42.83M CNY in the quarter ending June 30, 2026, a decrease of -44.59%. This brings the company's revenue in the last twelve months to 350.56M, down -11.23% year-over-year. In the year 2025, Guangdong Jiaying Pharmaceutical had annual revenue of 383.75M with 2.02% growth.
Revenue (ttm)
350.56M
Revenue Growth
-11.23%
P/S Ratio
5.50
Revenue / Employee
590.17K
Employees
594
Market Cap
1.93B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 383.75M | 7.58M | 2.02% |
| Dec 31, 2024 | 376.17M | -157.07M | -29.46% |
| Dec 31, 2023 | 533.23M | -125.96M | -19.11% |
| Jan 1, 2023 | 659.20M | 84.48M | 14.70% |
| Jan 1, 2022 | 574.71M | 29.98M | 5.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Int'l Group | 34.20B |
| Zhejiang Zhenyuan Share | 1.86B |
| Shanghai Shenqi Pharmaceutical Investment Management | 1.84B |
| GuangYuYuan Chinese Herbal Medicine | 1.41B |
| Hangzhou Minsheng Healthcare | 854.51M |
| Chongqing Lummy Pharmaceutical | 748.94M |
| Hangzhou Bio-Sincerity Pharma-Tech | 709.72M |
| Hubei Guangji Pharmaceutical | 651.57M |